County
Lake County Emergency Medical System
The current listed document is more than 24 months old and may be outdated.
Drugs and doses35
A–C Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Calcium Chloride6
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 6 mg | IV | not captured | standing | pages 66, 67 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | pages 172, 173 |
| SVT | adult | 6 mg | IV | not captured | standing | pages 66, 67, 172, 173, 200 |
| SVT | adult | 6 mg | IV | not captured | standing | page 200 |
| SVT | peds | 0.1 mg/kg | IV | not captured | standing | pages 66, 67, 172, 173, 200 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | pages 82, 83, 88, 89, 146, 176, 177, 184, 185, 201 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | pages 82, 83, 88, 89, 146, 176, 177, 184, 185, 201 |
| Other | adult | 2.5 mg | NEB | not captured | standing | page 89 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 300 mg | IV/IO | not captured | standing | pages 69, 168, 169, 202 |
| Other | peds | 5 mg/kg | IV | not captured | standing | page 202 |
| Other | peds | 5 mg/kg | IV/IO | not captured | standing | pages 69, 168, 169, 202 |
| Wide-complex tachycardia | adult | 150 mg | IV | not captured | standing | pages 68, 69, 70, 71, 168, 169, 173, 202 |
| Wide-complex tachycardia | peds | 5 mg/kg | IV | not captured | standing | pages 68, 69, 70, 71, 168, 169, 173, 202 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | pages 68, 69, 70, 71, 168, 169, 173, 202 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | pages 68, 69, 70, 71, 168, 169, 173, 202 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | pages 58, 59, 203 |
| Other | adult | 324 mg | not captured | not captured | standing | page 203 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 0.5 mg | IV/IO | not captured | standing | pages 63, 170, 171, 204 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 63, 170, 171, 204 |
| Organophosphate poisoning | adult | 2–4 mg | IV | not captured | standing | page 94 |
| Other | adult | 1 mg | IV | not captured | standing | page 63 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 g | IV/IO | not captured | standing | pages 60, 61, 68, 70, 94, 166, 167, 206 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 20 mg/kg | IV/IO | not captured | standing | pages 60, 61, 68, 70, 94, 166, 167, 206 |
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | pages 60, 61, 68, 70, 94, 166, 167, 206 |
| Hyperkalemia | peds | 20 mg/kg | IV/IO | not captured | standing | pages 60, 61, 68, 70, 94, 166, 167, 206 |
| Other | adult | 1 g | IV/IO | not captured | standing | pages 60, 61, 68, 70, 94, 166, 167, 206 |
| Other | adult | 1 g | IV/IO | not captured | standing | pages 60, 61, 68, 70, 94, 166, 167, 206 |
| Other | adult | 1 g | IV/IO | not captured | standing | page 94 |
| Other | adult | 1 g | not captured | not captured | standing | page 206 |
| Other | adult | 1 g | IV/IO | not captured | standing | pages 60, 61 |
| Other | peds | 20 mg/kg | IV/IO | not captured | standing | pages 60, 61, 68, 70, 94, 166, 167, 206 |
| Other | peds | 20 mg/kg | IV/IO | not captured | standing | pages 60, 61, 68, 70, 94, 166, 167, 206 |
| Other | peds | 20 mg/kg | not captured | not captured | standing | page 206 |
D–F Dextrose, Diazepam, Diltiazem, Diphenhydramine, Dopamine, Epinephrine, Fentanyl7
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 25 g | IV | not captured | standing | page 208 |
| Hypoglycemia | adult | 2.5 mL/kg | IV | not captured | standing | page 208 |
| Hypoglycemia | peds | 5 mL/kg | IV | not captured | standing | page 208 |
| Other | adult | 2.5 mL/kg | IV | not captured | standing | page 97 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | peds | 0.4 mL | PR | not captured | standing | page 322 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 0.25 mg/kg | IV | not captured | standing | page 207 |
| Atrial fibrillation with RVR | adult | 0.25 mg/kg | IV | not captured | standing | page 207 |
| Other | adult | 0.25 mg/kg | IV | not captured | standing | page 207 |
| Other | adult | 10 mg | IV | not captured | standing | pages 66, 67 |
| SVT | adult | 0.25 mg/kg | IV | not captured | standing | page 207 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 25–50 mg | IV/IO/IM | not captured | standing | page 209 |
| Allergic reaction | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 209 |
| Dystonic reaction | adult | 25–50 mg | IV/IO/IM | not captured | standing | page 209 |
| Dystonic reaction | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 209 |
| Other | adult | 1 mg/kg | IV | not captured | standing | pages 88, 89 |
| Other | adult | 1 mg/kg | IV/IM | not captured | standing | page 105 |
| Other | adult | 25–50 mg | IV/IO/IM | not captured | standing | page 209 |
| Other | adult | 25 mg | IV/IM | not captured | standing | page 84 |
| Other | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 209 |
| Other | peds | 1 mg/kg | IV/IM | not captured | standing | pages 176, 177 |
| Other | peds | 1 mg/kg | IV/IM | not captured | standing | page 177 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 5–20 mcg/kg | IV | not captured | standing | page 210 |
| Hypotension / shock | peds | 1–5 mcg/kg | IV | not captured | standing | page 210 |
| Other | adult | 5 mcg/kg | not captured | not captured | standing | page 210 |
| Other | peds | 1–5 mcg/kg | not captured | not captured | standing | page 210 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 2–8 mcg | IV | not captured | standing | page 211 |
| Other | adult | 0.3–0.5 mg | IM | not captured | standing | page 211 |
| Other | adult | 0.3 mg | IM | not captured | standing | pages 82, 184, 211 |
| Other | peds | 0.01 mg/kg | IM | not captured | standing | pages 82, 184, 211 |
| Other | peds | 0.01 mg/kg | IM | not captured | standing | page 211 |
| Other | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 211 |
| Other | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 211 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Burns | adult | 0.25–1 mcg/kg | IV | not captured | standing | page 118 |
| Post-intubation sedation | adult | 0.5 mcg/kg | IV | not captured | standing | pages 78, 79 |
G–L Glucagon, Haloperidol, Hydroxocobalamin, Ipratropium, Ketamine, Labetalol, Lidocaine, Lorazepam8
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | page 213 |
| Hypoglycemia | peds | 0.1 mg/kg | IM | not captured | standing | page 213 |
| Other | adult | 0.5 mg | IV | not captured | standing | page 213 |
| Other | adult | 1 mg | IV | not captured | standing | page 87 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | page 213 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 5–10 mg | IM | not captured | standing | pages 104, 105, 128, 129, 214 |
| Agitation | peds | 2.5–5 mg | IM | not captured | standing | pages 104, 105, 128, 129, 214 |
| Other | adult | 2.5–5 mg | IM | not captured | standing | page 105 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV/IO | not captured | standing | pages 76, 331 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | pages 82, 83, 88, 89, 146, 176, 177, 184, 185, 205 |
| Asthma / bronchospasm | peds | 0.5 mg | NEB | not captured | standing | pages 82, 83, 88, 89, 146, 176, 177, 184, 185, 205 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 100 mg | not captured | not captured | standing | page 324 |
| Other | adult | 104 mg | not captured | not captured | standing | page 324 |
| Other | adult | 108 mg | not captured | not captured | standing | page 324 |
| Other | adult | 114 mg | not captured | not captured | standing | page 324 |
| Other | adult | 118 mg | not captured | not captured | standing | page 324 |
| Other | adult | 124 mg | not captured | not captured | standing | page 324 |
| Other | adult | 128 mg | not captured | not captured | standing | page 324 |
| Other | adult | 132 mg | not captured | not captured | standing | page 324 |
| Other | adult | 136 mg | not captured | not captured | standing | page 324 |
| Other | adult | 142 mg | not captured | not captured | standing | page 324 |
| Other | adult | 146 mg | not captured | not captured | standing | page 324 |
| Other | adult | 150 mg | not captured | not captured | standing | page 324 |
| Other | adult | 2 mg/kg | IV/IO | not captured | standing | pages 78, 79, 187, 215 |
| Other | adult | 60 mg | not captured | not captured | standing | page 324 |
| Other | adult | 64 mg | not captured | not captured | standing | page 324 |
| Other | adult | 66 mg | not captured | not captured | standing | page 324 |
| Other | adult | 68 mg | not captured | not captured | standing | page 324 |
| Other | adult | 72 mg | not captured | not captured | standing | page 324 |
| Other | adult | 76 mg | not captured | not captured | standing | page 324 |
| Other | adult | 82 mg | not captured | not captured | standing | page 324 |
| Other | adult | 86 mg | not captured | not captured | standing | page 324 |
| Other | adult | 90 mg | not captured | not captured | standing | page 324 |
| Other | adult | 96 mg | not captured | not captured | standing | page 324 |
| Other | peds | 0.5–2 mg/kg | not captured | not captured | standing | page 187 |
| Other | peds | 1–2 mg/kg | IV/IO | not captured | standing | pages 78, 79, 187, 215 |
| Other | peds | 20 mg | not captured | not captured | standing | pages 186, 324 |
| Other | peds | 24 mg | not captured | not captured | standing | pages 186, 324 |
| Other | peds | 2 mg/kg | not captured | not captured | standing | pages 186, 324 |
| Other | peds | 2 mg/kg | IV/IO | not captured | standing | page 187 |
| Other | peds | 30 mg | not captured | not captured | standing | pages 186, 324 |
| Other | peds | 34 mg | not captured | not captured | standing | pages 186, 324 |
| Other | peds | 40 mg | not captured | not captured | standing | pages 186, 324 |
| Other | peds | 44 mg | not captured | not captured | standing | pages 186, 324 |
| Other | peds | 50 mg | not captured | not captured | standing | pages 186, 324 |
| Other | peds | 54 mg | not captured | not captured | standing | pages 186, 324 |
| Post-intubation sedation | adult | 1–2 mg/kg | IV | not captured | standing | page 78 |
| Procedural sedation | adult | 2 mg/kg | not captured | not captured | standing | page 215 |
| Procedural sedation | peds | 2 mg/kg | not captured | not captured | standing | page 215 |
| RSI induction | adult | 2 mg/kg | IV/IO | not captured | standing | pages 78, 79, 187, 215 |
| RSI induction | peds | 2 mg/kg | IV/IO | not captured | standing | pages 78, 79, 187, 215 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 5 mg | IV | not captured | standing | pages 98, 99, 154, 155, 216 |
| Other | adult | 5 mg | IV | not captured | standing | pages 98, 99, 216 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 40 mg | IO | not captured | standing | pages 218, 282 |
| Mild to moderate pain | adult | 40 mg | IO | not captured | standing | pages 218, 281, 282 |
| Mild to moderate pain | peds | 0.5 mg/kg | IO | not captured | standing | pages 218, 281, 282 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 1–2 mg | IV/IM | not captured | standing | page 232 |
| Agitation | peds | 0.05 mg/kg | IV/IM | not captured | standing | page 232 |
| Other | adult | 1–2 mg | IV/IM | not captured | standing | page 232 |
| Other | adult | 1–2 mg | IV/IM | not captured | standing | page 232 |
| Other | peds | 0.05 mg/kg | IV/IM | not captured | standing | page 232 |
| Other | peds | 0.05 mg/kg | IV/IM | not captured | standing | page 232 |
| Procedural sedation | adult | 1–2 mg | IV/IM | not captured | standing | page 232 |
| Procedural sedation | peds | 0.05 mg/kg | IV/IM | not captured | standing | page 232 |
| Status epilepticus | adult | 1–2 mg | IV/IM | not captured | standing | page 232 |
| Status epilepticus | peds | 0.05 mg/kg | IV/IM | not captured | standing | page 232 |
M–O Magnesium Sulfate, Methylprednisolone, Midazolam, Morphine, Naloxone, Nitroglycerin, Norepinephrine, Ondansetron, Oral Glucose9
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Eclampsia / pre-eclampsia | adult | 4 g | IV | not captured | standing | pages 154, 155, 219 |
| Eclampsia / pre-eclampsia | adult | 4 g | IV | not captured | standing | pages 154, 155, 219 |
| Eclampsia / pre-eclampsia | adult | 4 g | IV | not captured | standing | pages 154, 155 |
| Eclampsia / pre-eclampsia | adult | 4–5 g | IV | not captured | standing | pages 154, 155, 219 |
| Other | adult | 1–2 g | IV | not captured | standing | pages 82, 83, 219 |
| Other | adult | 2 g | IV | not captured | standing | pages 82, 83, 219 |
| Other | peds | 25–75 mg/kg | IV | not captured | standing | pages 82, 83, 219 |
| Other | peds | 25–75 mg/kg | IV | not captured | standing | pages 82, 83, 219 |
| VF / pulseless VT | adult | 1–2 g | IV/IO | not captured | standing | pages 68, 69, 70, 71, 168, 169, 219 |
| VF / pulseless VT | adult | 2 g | IV/IO | not captured | standing | pages 68, 69, 70, 71, 168, 169, 219 |
| VF / pulseless VT | peds | 50 mg/kg | IV/IO | not captured | standing | pages 68, 69, 70, 71, 168, 169, 219 |
| VF / pulseless VT | peds | 50 mg/kg | IV/IO | not captured | standing | pages 68, 69, 70, 71, 168, 169, 219 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 125 mg | IV/IM | not captured | standing | pages 88, 89, 176, 177, 228 |
| Allergic reaction | peds | 2 mg/kg | IV/IM | not captured | standing | pages 88, 89, 176, 177, 228 |
| Asthma / bronchospasm | adult | 125 mg | IV/IM | not captured | standing | pages 82, 83, 184, 185, 228 |
| Asthma / bronchospasm | peds | 2 mg/kg | IV/IM | not captured | standing | pages 82, 83, 184, 185, 228 |
| COPD | adult | 125 mg | IV/IM | not captured | standing | pages 82, 83, 184, 185, 228 |
| COPD | peds | 2 mg/kg | IV/IM | not captured | standing | pages 82, 83, 184, 185, 228 |
| Other | adult | 125 mg | IV | not captured | standing | page 82 |
| Other | peds | 2 mg/kg | IV/IM | not captured | standing | pages 176, 177 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2.5 mg | IV/IM | not captured | standing | pages 72, 78, 79, 187 |
| Other | adult | 2.5 mg | IV | not captured | standing | page 72 |
| Other | adult | 2.5 mg | IV | not captured | standing | page 63 |
| Other | adult | 2.5 mg | IV | not captured | standing | page 71 |
| Other | adult | 2.5 mg | IV/IM | not captured | standing | page 105 |
| Other | adult | 5 mg | IM | not captured | standing | page 72 |
| Other | adult | 5 mg | IV | not captured | standing | page 79 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | page 187 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | page 220 |
| Other | peds | 0.1 mg/kg | IV/IM | not captured | standing | pages 72, 78, 79, 187 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | page 187 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | page 188 |
| Other | peds | 0.2 mg/kg | IM | not captured | standing | page 188 |
| Post-intubation sedation | adult | 2.5–5 mg | IV | not captured | standing | pages 78, 79 |
| Procedural sedation | adult | 2.5 mg | IV/IO | not captured | standing | pages 63, 318 |
| Seizure | adult | 2.5 mg | IV | not captured | standing | pages 106, 107 |
| Seizure | adult | 5–15 mg | IV | not captured | standing | pages 106, 107, 188, 189, 220 |
| Seizure | peds | 0.1 mg/kg | IV | not captured | standing | pages 106, 107, 188, 189, 220 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Burns | adult | 2 mg | IV/IM | not captured | standing | page 232 |
| Burns | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 232 |
| Other | adult | 2 mg | IV/IM | not captured | standing | page 232 |
| Other | adult | 2 mg | IV/IM | not captured | standing | page 232 |
| Other | adult | 2 mg | IV/IM | not captured | standing | page 232 |
| Other | adult | 2 mg | IV | not captured | standing | page 232 |
| Other | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 232 |
| Other | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 232 |
| Other | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 232 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | page 232 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4–2 mg | IV | not captured | standing | pages 94, 95, 221 |
| Opioid overdose | adult | 0.4–2 mg | IM | not captured | standing | pages 94, 95, 221 |
| Opioid overdose | adult | 0.4–2 mg | IV/IM/IN | not captured | standing | pages 94, 95, 166, 167, 183, 189, 221 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IM/IN | not captured | standing | pages 94, 95, 166, 167, 183, 189, 221 |
| Other | adult | 0.5 mg | IV | not captured | standing | page 90 |
| Other | adult | 0.5 mg | IV/IM | not captured | standing | page 95 |
| Other | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 167 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | page 183 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | page 166 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | pages 58, 222 |
| CHF / pulmonary edema | adult | 0.4 mg | ODT | not captured | standing | pages 82, 83 |
| Other | adult | 0.4 mg | ODT | not captured | standing | page 58 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 10 mcg | IV | not captured | standing | pages 59, 62, 63, 64, 65, 72, 73, 82, 108, 109, 112, 113, 191, 217 |
| Hypotension / shock | peds | 0.1 mcg/kg | IV | not captured | standing | pages 59, 62, 63, 64, 65, 72, 73, 82, 108, 109, 112, 113, 191, 217 |
| Other | adult | 10 mcg | IV | not captured | standing | pages 62, 63 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 4 mg | IV | not captured | standing | page 58 |
| Nausea / vomiting | adult | 4 mg | IV/IM/ODT | not captured | standing | pages 58, 59, 84, 85, 89, 93, 99, 103, 174, 175, 179, 231 |
| Nausea / vomiting | peds | 2 mg | IV/IM/ODT | not captured | standing | pages 58, 59, 84, 85, 89, 93, 99, 103, 174, 175, 179, 231 |
| Other | adult | 4 mg | IM/ODT | not captured | standing | page 84 |
| Other | adult | 4 mg | IM | not captured | standing | pages 98, 99 |
| Other | adult | 4 mg | ODT | not captured | standing | page 85 |
| Other | adult | 4 mg | IM/ODT | not captured | standing | page 59 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15–45 g | PO | not captured | standing | page 223 |
| Hypoglycemia | peds | 5–45 g | PO | not captured | standing | page 223 |
P–R Pralidoxime, Rocuronium2
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 600 mg | IM | not captured | standing | pages 147, 331 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1 mg/kg | IV/IO | not captured | standing | pages 79, 225 |
| RSI induction | peds | 1 mg/kg | IV/IO | not captured | standing | pages 79, 225 |
S–Z Sodium Bicarbonate, Succinylcholine, Tranexamic Acid3
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 50 mEq | IV/IO | not captured | standing | pages 60, 61, 123, 226 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 60, 61, 123, 226 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 60, 61, 166, 226 |
| Other | adult | 2.5 mL | NEB | not captured | standing | page 146 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 60, 61, 166, 226 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 166, 167 |
| Tricyclic overdose | adult | 1 mEq/kg | IV | not captured | standing | pages 94, 226 |
| Tricyclic overdose | peds | 1 mEq/kg | IV | not captured | standing | pages 94, 226 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–2 mg/kg | not captured | not captured | standing | page 229 |
| Other | peds | 1.5 mg/kg | IV | not captured | standing | page 187 |
| Other | peds | 2 mg/kg | not captured | not captured | standing | page 229 |
| RSI induction | adult | 100 mg | IV | not captured | standing | pages 79, 229, 270 |
| RSI induction | peds | 2 mg/kg | IV | not captured | standing | pages 79, 229 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g | IV | not captured | standing | pages 130, 131, 230 |
| Other | peds | 15 mg/kg | IV | not captured | standing | pages 193, 230 |
| Trauma / hemorrhage | adult | 1 g | IV | not captured | standing | pages 130, 131, 230 |
| Trauma / hemorrhage | peds | 1000 mg | IV | not captured | standing | pages 130, 131, 230 |
| Trauma / hemorrhage | peds | 15 mg/kg | IV | not captured | standing | pages 130, 131, 230 |
Cite this
Lake County Emergency Medical System, United States EMS Protocol Census. 226 dose entries, effective 2022-03-01.
https://protoquiz.com/census/agencies/lake-county-emergency-medical-system/
The census is free and not for sale. Only public agencies are named.